Compare CMPS & PRAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CMPS | PRAA |
|---|---|---|
| Founded | 2020 | 1996 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 611.6M | 536.5M |
| IPO Year | 2020 | N/A |
| Metric | CMPS | PRAA |
|---|---|---|
| Price | $6.85 | $17.52 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 3 |
| Target Price | $16.43 | ★ $24.33 |
| AVG Volume (30 Days) | ★ 1.4M | 423.4K |
| Earning Date | 11-04-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,161,679,000.00 |
| Revenue This Year | N/A | $7.85 |
| Revenue Next Year | N/A | $7.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.41 |
| 52 Week Low | $2.25 | $12.29 |
| 52 Week High | $7.15 | $23.97 |
| Indicator | CMPS | PRAA |
|---|---|---|
| Relative Strength Index (RSI) | 62.97 | 59.84 |
| Support Level | $6.08 | $16.55 |
| Resistance Level | $7.15 | $18.37 |
| Average True Range (ATR) | 0.41 | 0.67 |
| MACD | 0.07 | -0.05 |
| Stochastic Oscillator | 80.45 | 55.03 |
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
PRA Group Inc is a leader in acquiring and collecting nonperforming loans. The company returns capital to banks and other creditors to help expand financial services for consumers in the Americas, Europe, and Australia. It is also engaged in providing fee-based services on class action claims recoveries in the United States. The company's portfolio segments include; Core, which is engaged in purchasing and collecting nonperforming loans, which the originators have not chosen not to pursue, and the Insolvency segment which is engaged in purchasing and collecting nonperforming loans where the customer is involved in a bankruptcy proceeding.